Nanotechnology researchers have designed a preliminary microneedle patch containing cerium nanoparticles that could combat ...

Hudson Therapeutics, a leading innovator in therapeutic solutions and a US subsidiary of Shaperon, announced Shaperon's entry into the $9.58 billion global market for alopecia areata treatment. This ...

Lumenis Be. Ltd., a leading energy-based medical device company for aesthetic and eye care solutions, announced a new ...

Lumenis Be. Ltd., a leading energy-based medical device company for aesthetic and eye care solutions, announced a new ...

The FDA's breakthrough tag is given to certain medical devices that provide treatment or diagnosis of life-threatening conditions so when the government gives such designation, it is aimed at speeding ...

but could take the lead in alopecia areata (AA), a common cause of hair loss. The FDA has granted Lilly a breakthrough designation (BTD) for JAK inhibitor Olumiant (baricitinib) in AA, an ...

Scientists have yet to find a cure for this potentially severe form of viral hepatitis, which affects anywhere from 2.4 million to 4.7 million people in the United States. This article takes a look at ...

BridgeBio said it received breakthrough therapy designation from the U.S. Food and Drug Administration for infigratinib, a treatment under development for children with achondroplasia. The ...

A best-selling anti-baldness drug that lowers male hormone levels also cuts the risk of prostate cancer, say US scientists. Proscar, which helps stop hair from thinning, was found to reduce the ...

The announcement follows a February 2023 proof-of-concept study that showed COYA 302's dual-mechanism immunotherapy to be well tolerated in a small cohort of ALS patients over a 48-week treatment ...

A double breakthrough in the war against malaria could lead to a cure for the disease which kills a child every 20 seconds. Scientists say they have cracked the genetic code of both the mosquito ...